• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国武汉人群中的 Epstein-Barr 病毒 EA-IgA、VCA-IgA 和 EBVNA-IgG 抗体。

Epstein-Barr Virus EA-IgA, VCA-IgA, and EBVNA-IgG Antibodies in a Population of Wuhan, China.

机构信息

Department of Otolaryngology, Huazhong University of Science and Technology, Wuhan, 430022, China.

Physical Examination Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

出版信息

Curr Med Sci. 2020 Feb;40(1):168-171. doi: 10.1007/s11596-020-2160-x. Epub 2020 Mar 13.

DOI:10.1007/s11596-020-2160-x
PMID:32166679
Abstract

The study investigated the distribution of Epstein-Barr virus (EBV) EA-IgA, VCA-IgA, and EBVNA-IgG antibodies in a local population of Wuhan, China. Chemiluminescence immunoassay (CLIA) was used to detect EBV EA-IgA, VCA-IgA, and EBVNA-IgG antibodies in 972 subjects undergoing physical examination in Wuhan, and the results were analyzed. The detection rate of EBV was positively correlated with age. In the 972 cases, there was significant difference between different genders in the positive rate of VCA-IgA and EBVNA-IgG. Moreover, the positive rate of VCA-IgA and EBVNA-IgG was higher in men ≥ 60 years old than in those < 60 but no significant differences were found in three antibodies among various age groups. Our results suggested that the EBV infection should be intensively monitored in elderly people in Wuhan.

摘要

本研究调查了武汉地区人群中 Epstein-Barr 病毒 (EBV) EA-IgA、VCA-IgA 和 EBVNA-IgG 抗体的分布。采用化学发光免疫分析法 (CLIA) 检测了武汉 972 例体检人群的 EBV EA-IgA、VCA-IgA 和 EBVNA-IgG 抗体,并对结果进行了分析。EBV 的检出率与年龄呈正相关。在 972 例患者中,VCA-IgA 和 EBVNA-IgG 的阳性率在不同性别间存在显著差异,且男性≥60 岁者 VCA-IgA 和 EBVNA-IgG 的阳性率高于<60 岁者,但三组抗体在各年龄段间的阳性率差异均无统计学意义。我们的研究结果提示,武汉地区老年人应加强 EBV 感染的监测。

相似文献

1
Epstein-Barr Virus EA-IgA, VCA-IgA, and EBVNA-IgG Antibodies in a Population of Wuhan, China.中国武汉人群中的 Epstein-Barr 病毒 EA-IgA、VCA-IgA 和 EBVNA-IgG 抗体。
Curr Med Sci. 2020 Feb;40(1):168-171. doi: 10.1007/s11596-020-2160-x. Epub 2020 Mar 13.
2
Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒抗体(VCA/IgA、EA/IgA、Rta/IgG和EBNA1/IgA)联合检测对鼻咽癌的诊断意义
Asian Pac J Cancer Prev. 2014;15(5):2001-6. doi: 10.7314/apjcp.2014.15.5.2001.
3
Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China.建立基于 VCA 和 EBNA1 IgA 的酶联免疫吸附试验组合作为鼻咽癌的首选筛查方法:在中国南方进行的两阶段设计的初步性能研究和大规模筛查。
Int J Cancer. 2012 Jul 15;131(2):406-16. doi: 10.1002/ijc.26380. Epub 2011 Nov 19.
4
Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis.血清中EB病毒抗体EA-IgA、Rta-IgG、VCA-IgA及SA的表达及其联合检测在鼻咽癌诊断中的意义
Int J Clin Exp Pathol. 2015 Dec 1;8(12):16104-10. eCollection 2015.
5
[Six anti-Epstein-Barr virus antibodies in healthy adults in a high risk area of nasopharyngeal carcinoma].[鼻咽癌高风险地区健康成年人中的六种抗爱泼斯坦-巴尔病毒抗体]
Ai Zheng. 2009 Aug;28(8):822-6. doi: 10.5732/cjc.009.10095.
6
Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.2013-2017 年期间北京的抗 EBV 抗体:我们在不同患者中发现了什么。
PLoS One. 2018 Mar 1;13(3):e0193171. doi: 10.1371/journal.pone.0193171. eCollection 2018.
7
Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay.爱泼斯坦-巴尔病毒抗体EA-IgG、Rta-IgG和VCA-IgA在鼻咽癌中的表达及其在联合诊断检测中的应用。
Genet Mol Res. 2016 Mar 18;15(1):gmr7368. doi: 10.4238/gmr.15017368.
8
Prognostic value of serum Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma and undetectable pretreatment Epstein-Barr virus DNA.血清爱泼斯坦-巴尔病毒抗体在鼻咽癌患者及治疗前爱泼斯坦-巴尔病毒DNA检测不到的患者中的预后价值
Cancer Sci. 2017 Aug;108(8):1640-1647. doi: 10.1111/cas.13296. Epub 2017 Jul 13.
9
[Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].[不同临床分期下爱泼斯坦-巴尔病毒Rta-IgG、VCA-IgA、EA-IgA及爱泼斯坦-巴尔病毒DNA检测法在鼻咽癌诊断中的评估]
Zhonghua Yi Xue Za Zhi. 2013 Nov 26;93(44):3516-9.
10
[Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA].鼻咽癌临床分期与爱泼斯坦-巴尔病毒抗体Rta/IgG、EBNA1/IgA、VCA/IgA和EA/IgA的关系
Nan Fang Yi Ke Da Xue Xue Bao. 2010 Mar;30(3):509-11.

引用本文的文献

1
Equity in protection: bridging global data gaps for an EBV vaccine-a systematic review and meta-analysis.保护公平性:弥合全球EBV疫苗数据差距——一项系统评价与荟萃分析
BMJ Glob Health. 2025 Aug 14;10(8):e015534. doi: 10.1136/bmjgh-2024-015534.
2
Epidemiological characteristics of three herpesviruses infections in children in Nanjing, China, from 2018 to 2023.中国南京地区 2018 年至 2023 年三种疱疹病毒感染的流行病学特征。
Front Cell Infect Microbiol. 2024 Oct 3;14:1448533. doi: 10.3389/fcimb.2024.1448533. eCollection 2024.
3
Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma.

本文引用的文献

1
Epstein-Barr virus in systemic autoimmune diseases.系统性自身免疫性疾病中的爱泼斯坦-巴尔病毒
Clin Dev Immunol. 2013;2013:535738. doi: 10.1155/2013/535738. Epub 2013 Aug 24.
2
Salivary gland and nasopharyngeal cancers in individuals with acquired immunodeficiency syndrome in United States.美国获得性免疫缺陷综合征个体中的唾液腺癌和鼻咽肿瘤。
Int J Cancer. 2010 May 15;126(10):2503-8. doi: 10.1002/ijc.24930.
3
Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.Cripto-1过表达参与鼻咽癌的肿瘤发生。
化学发光免疫分析法检测EB病毒VCA-IgA和EBNA1-IgA抗体在鼻咽癌诊断中的效能
J Cancer. 2020 Oct 18;11(24):7176-7183. doi: 10.7150/jca.47260. eCollection 2020.
BMC Cancer. 2009 Sep 6;9:315. doi: 10.1186/1471-2407-9-315.
4
Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.爱泼斯坦-巴尔病毒血清学在鼻咽癌早期检测与筛查中的应用
Ai Zheng. 2006 Feb;25(2):250-6.
5
Nasopharyngeal carcinoma.鼻咽癌
Lancet. 2005;365(9476):2041-54. doi: 10.1016/S0140-6736(05)66698-6.
6
Epstein-Barr virus and cancer.爱泼斯坦-巴尔病毒与癌症
Clin Cancer Res. 2004 Feb 1;10(3):803-21. doi: 10.1158/1078-0432.ccr-0670-3.
7
Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome.重症慢性活动性EB病毒感染综合征概述及问题观点
Crit Rev Oncol Hematol. 2002 Dec;44(3):273-82. doi: 10.1016/s1040-8428(02)00118-x.
8
Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum.基于EB病毒抗体谱评估鼻咽癌风险。
Int J Cancer. 2002 Feb 1;97(4):489-92. doi: 10.1002/ijc.1641.